tetradecanoylphorbol acetate has been researched along with Diabetes Mellitus in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (6.25) | 18.7374 |
1990's | 9 (56.25) | 18.2507 |
2000's | 4 (25.00) | 29.6817 |
2010's | 1 (6.25) | 24.3611 |
2020's | 1 (6.25) | 2.80 |
Authors | Studies |
---|---|
Basyreva, LY; Gusev, SA; Lipatova, VA; Mikhalchik, EV; Panasenko, OM; Sergienko, VI | 1 |
Collard, E; Roy, S | 1 |
Balasubramanyam, M; Koteswari, AA; Kumar, RS; Maheswari, JU; Mohan, V; Monickaraj, SF | 1 |
Fowler, A; Galiñanes, M; Hassouna, A; Loubani, M; Matata, BM; Standen, NB | 1 |
Ding, Y; Hasturk, H; Kantarci, A; Malabanan, A; Trackman, PC; Van Dyke, TE | 1 |
Eilen, SD; Shah, SV; Wallin, JD | 1 |
Candlish, JK; Lin, X; Thai, AC | 1 |
Chen, J; Egawhary, DN; Swoboda, BE; Vince, FP | 1 |
Inoue, S; Lan, Y; Muran, J; Tsuji, M | 1 |
Cinotti, GA; Di Mario, U; Menè, P; Pricci, F; Pugliese, F; Pugliese, G | 1 |
Castle, GE; Saeed, FA | 1 |
Caimi, G; Canino, B; Catania, A; LoPresti, R; Montana, M; Ventimiglia, G | 1 |
Chaushev, TA; Dakovska, LN; Ivanov, GI; Kyurkchiev, SD | 1 |
Blodgett, JL; Bloodworth, RC; McManus, LM; Pinckard, RN; Prihoda, TJ | 1 |
Federlin, K; Marhoffer, W; Schleinkofer, L; Stein, M | 1 |
Taniguchi, N | 1 |
1 review(s) available for tetradecanoylphorbol acetate and Diabetes Mellitus
Article | Year |
---|---|
Clinical significances of superoxide dismutases: changes in aging, diabetes, ischemia, and cancer.
Topics: Aging; Diabetes Mellitus; Female; Humans; Ischemia; Male; Neoplasms; Superoxide Dismutase; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 1992 |
15 other study(ies) available for tetradecanoylphorbol acetate and Diabetes Mellitus
Article | Year |
---|---|
Hyperglycemia and Some Aspects of Leukocyte Activation In Vitro.
Topics: Diabetes Mellitus; Extracellular Traps; Humans; Hyperglycemia; Leukocytes; Luminescent Measurements; Neutrophils; Reactive Oxygen Species; Tetradecanoylphorbol Acetate; Zymosan | 2021 |
Improved function of diabetic wound-site macrophages and accelerated wound closure in response to oral supplementation of a fermented papaya preparation.
Topics: Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Blood; Blood Glucose; Body Weight; Carica; Diabetes Complications; Diabetes Mellitus; Dietary Supplements; Endothelial Cells; Fermentation; Fruit; Gene Expression; Insulin; Lipids; Lipopolysaccharides; Lipoproteins; Macrophages; Male; Mice; Mice, Obese; Nitric Oxide; Nitric Oxide Synthase Type II; Plant Preparations; Platelet Endothelial Cell Adhesion Molecule-1; Reactive Oxygen Species; Superoxides; Tetradecanoylphorbol Acetate; Vascular Endothelial Growth Factor A; Wound Healing; Wounds and Injuries | 2010 |
Curcumin-induced inhibition of cellular reactive oxygen species generation: novel therapeutic implications.
Topics: Calcium; Case-Control Studies; Curcumin; Diabetes Mellitus; Humans; Protein Kinase C; Reactive Oxygen Species; Tetradecanoylphorbol Acetate | 2003 |
Mitochondrial dysfunction as the cause of the failure to precondition the diabetic human myocardium.
Topics: Adenosine; Adrenergic alpha-Agonists; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diazoxide; Enzyme Activation; Glyburide; Heart Atria; Humans; Hypoglycemic Agents; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Membrane Potentials; Metformin; Mitochondria, Heart; Myocardial Ischemia; p38 Mitogen-Activated Protein Kinases; Phenylephrine; Potassium Channels; Protein Kinase C; Reactive Oxygen Species; Tetradecanoylphorbol Acetate | 2006 |
Activation of RAGE induces elevated O2- generation by mononuclear phagocytes in diabetes.
Topics: Adult; Diabetes Mellitus; Female; Glucose; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Hyperglycemia; Male; Middle Aged; Monocytes; N-Formylmethionine Leucyl-Phenylalanine; Nerve Growth Factors; Receptor for Advanced Glycation End Products; Receptors, Immunologic; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Structure-Activity Relationship; Superoxides; Tetradecanoylphorbol Acetate; Zymosan | 2007 |
Chemiluminescence and superoxide anion production by leukocytes from diabetic patients.
Topics: Adult; Aged; Anions; Diabetes Mellitus; Glucagon; Humans; Kinetics; Luminescent Measurements; Middle Aged; Neutrophils; Opsonin Proteins; Oxygen; Superoxides; Tetradecanoylphorbol Acetate; Zymosan | 1983 |
Superoxide production by neutrophils from diabetics and normal subjects in response to glucose and galactose.
Topics: Adult; Blood Glucose; Diabetes Mellitus; Female; Galactose; Glucose; Glycated Hemoglobin; Humans; In Vitro Techniques; Male; Middle Aged; Neutrophils; Reference Values; Superoxides; Tetradecanoylphorbol Acetate | 1993 |
Diabetic complications and the mechanism of the hyperglycaemia-induced damage to the mt DNA of cultured vascular endothelial cells: (II) The involvement of protein kinase C.
Topics: Cells, Cultured; Diabetes Complications; Diabetes Mellitus; DNA Damage; DNA, Mitochondrial; Endothelium, Vascular; Enzyme Activation; Glycation End Products, Advanced; Humans; Hyperglycemia; Protein Kinase C; Reactive Oxygen Species; Sequence Deletion; Tetradecanoylphorbol Acetate | 1995 |
Reduced hydrogen peroxide production in neutrophils from patients with diabetes.
Topics: Adult; Aged; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Flow Cytometry; Fluoresceins; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Hydrogen Peroxide; Male; Middle Aged; Neutrophils; Reference Values; Tetradecanoylphorbol Acetate; Time Factors | 1996 |
High glucose level inhibits capacitative Ca2+ influx in cultured rat mesangial cells by a protein kinase C-dependent mechanism.
Topics: Animals; Arginine Vasopressin; Calcium; Cells, Cultured; Diabetes Mellitus; Enzyme Activation; Fura-2; Glomerular Mesangium; Glucose; Models, Biological; Protein Kinase C; Rats; Staurosporine; Tetradecanoylphorbol Acetate | 1997 |
Neutrophil chemiluminescence during phagocytosis is inhibited by abnormally elevated levels of acetoacetate: implications for diabetic susceptibility to infections.
Topics: Acetoacetates; Diabetes Mellitus; Disease Susceptibility; Dose-Response Relationship, Drug; Humans; Luminescent Measurements; Neutrophil Activation; Neutrophils; Phagocytosis; Tetradecanoylphorbol Acetate | 1998 |
Diabetes mellitus: polymorphonuclear leukocyte (PMN) filtration parameters and PMN membrane fluidity after chemotactic activation.
Topics: Adolescent; Adult; Aged; Chemotaxis, Leukocyte; Diabetes Mellitus; Filtration; Humans; Membrane Fluidity; Middle Aged; N-Formylmethionine Leucyl-Phenylalanine; Neutrophil Activation; Neutrophils; Tetradecanoylphorbol Acetate | 1999 |
Increased adhesion of lymphoid cells to glycated proteins.
Topics: Animals; Cattle; Cell Adhesion; Diabetes Mellitus; Diabetic Angiopathies; Glycation End Products, Advanced; Glycoproteins; Humans; Jurkat Cells; Lymphocytes; Monocytes; Receptor for Advanced Glycation End Products; Receptors, Immunologic; T-Lymphocytes; Tetradecanoylphorbol Acetate; U937 Cells | 1999 |
Agonist-dependent failure of neutrophil function in diabetes correlates with extent of hyperglycemia.
Topics: Adult; Blood Glucose; Calcimycin; Cells, Cultured; Cross-Sectional Studies; Diabetes Mellitus; Female; Humans; Hyperglycemia; Leukotriene B4; Lysosomes; Male; Middle Aged; N-Formylmethionine Leucyl-Phenylalanine; Neutrophil Activation; Neutrophils; Platelet Activating Factor; Tetradecanoylphorbol Acetate; Zymosan | 2001 |
[Impaired induction of chemiluminescence and function of polymorphonuclear neutrophilic granulocytes in diabetes mellitus].
Topics: Diabetes Mellitus; Humans; In Vitro Techniques; Luminescent Measurements; Neutrophils; Phagocytosis; Respiratory Burst; Tetradecanoylphorbol Acetate | 1992 |